Download study summaries

Grandmother embracing granddaughter on the beach
MeMed logo

The immune system speaks.

We listen.

MeMed is transforming patient care by listening to the immune system and turning host response signals into clinical action.

MeMed BV - Bacterial or Viral?

®

We developed a pioneering test to help physicians with the seemingly simple clinical dilemma - is it a bacterial or viral infection? 

By providing host response information, we help physicians make more informed decisions about how and when to treat.

 

From a small serum sample, MeMed BV computationally integrates the level of three host immune proteins into a simple score indicating the likelihood of a bacterial immune response or co-infection versus a likely viral immune response.

4l.png
circles3_2.png

MeMed BV Performance

The study was conducted to establish the diagnostic performance of the MeMed BV test for differentiating bacterial from viral infection in patients with suspected acute bacterial or viral infection.


MeMed BV is uniquely both double-blind and externally validated.

MeMed BV performance goals independently confirmed in unprecedented validation and real-world usage encompassing >20,000 patients.

*Data on file. Based on secondary endpoint analysis in Apollo Clinical Study (NCT04690569).

1-7

Click to read the full articles here:

lancet_infectious_diseases.png
the_plos_2_.png
Pediatrics logo

Conventional tests are often insufficient because...

icon.png

Inaccessible infection sites

icon3.png

Often no pathogens are detected

icon2.png

​False alarms due to colonization

icon6.png

Prolonged time to results

icon5.png

Uncertainty regarding severity

MeMed Key

MeMed Key runs the MeMed BV test in just 15 minutes, where and when it actually matters.  MeMed Key is a cutting edge, compact immunoassay platform that is accurate and easy to use, making it possible to conduct highly sensitive, rapid, multiplexed protein measurements that previously could only be done on expensive central lab equipment.

The MeMed BV test and MeMed Key platform are FDA cleared.

®

About MeMed

At MeMed, a leader in host response technologies, we decode the body's complex signals into simple insights that improve people's lives. By leveraging our expertise in host-response profiling and machine-learning algorithms, we are creating a portfolio of tests that address tough clinical dilemmas.

Smiling mom with little son visiting doctor

Download our clinical study summaries

Phone icon
Location icon

5 Nahum Het St.
Tirat Carmel
39120,Israel

linkedin
facebook
Twitter icon

References:

1. Data on file. Apollo Clinical Study (NCT04690569) conducted to establish the diagnostic performance of the MeMed BV Test for differentiating bacterial from viral infection in patients with suspected acute bacterial or viral infection;  2. Oved, K. et al. PLoS One (2015)  3. van Houten, C. B. et al. OPPORTUNITY: Lancet Infect. Dis. (2016); 4. Srugo, I. et al. Pediatrics (2017); 5. Ashkenazi-Hoffnung, L. et al. EJC MID (2018); 6. Stein et al. DMID (2017); 7. Eden et al. JOI (2016)